Thomas DiRaimondo, Chief Scientific Officer at Janux Therapeutics, Inc. (JANX), sold 2,505 shares at $13.73 ($34K) on 2026-01-02, disclosed to the SEC on 2026-01-02.
Open-market sale of $34k JANX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.